Clinical Trial Update: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on allogeneic natural killer (NK) cells for ovarian, fallopian tube, peritoneal, and metastatic breast cancer; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-02-24